Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.

MLA

Oldach, Maureen S., et al. “Acute Pharmacodynamic Effects of Pimobendan in Client-Owned Cats with Subclinical Hypertrophic Cardiomyopathy.” BMC Veterinary Research, vol. 17, no. 1, Feb. 2021, p. 89. EBSCOhost, https://doi.org/10.1186/s12917-021-02799-9.

APA

Oldach, M. S., Ueda, Y., Ontiveros, E. S., Fousse, S. L., Visser, L. C., & Stern, J. A. (2021). Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy. BMC Veterinary Research, 17(1), 89. https://doi.org/10.1186/s12917-021-02799-9

Chicago

Oldach, Maureen S, Yu Ueda, Eric S Ontiveros, Samantha L Fousse, Lance C Visser, and Joshua A Stern. 2021. “Acute Pharmacodynamic Effects of Pimobendan in Client-Owned Cats with Subclinical Hypertrophic Cardiomyopathy.” BMC Veterinary Research 17 (1): 89. doi:10.1186/s12917-021-02799-9.